Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.57668554 |
2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.38263399 |
3 | positive regulation of B cell differentiation (GO:0045579) | 4.93160501 |
4 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.59679526 |
5 | regulation of B cell differentiation (GO:0045577) | 4.54292532 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.49580118 |
7 | modulation by symbiont of host defense response (GO:0052031) | 4.49580118 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.49580118 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.49580118 |
10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.49580118 |
11 | modulation by symbiont of host immune response (GO:0052553) | 4.49580118 |
12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.24765300 |
13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.24765300 |
14 | neutrophil activation involved in immune response (GO:0002283) | 4.20259445 |
15 | immunoglobulin mediated immune response (GO:0016064) | 4.16099390 |
16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.14279876 |
17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.13082634 |
18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.12831619 |
19 | detection of other organism (GO:0098543) | 4.07777535 |
20 | positive regulation of granulocyte differentiation (GO:0030854) | 4.03273614 |
21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.00827559 |
22 | positive thymic T cell selection (GO:0045059) | 3.97447770 |
23 | B cell receptor signaling pathway (GO:0050853) | 3.93964375 |
24 | detection of molecule of bacterial origin (GO:0032490) | 3.93210632 |
25 | negative regulation of T cell mediated immunity (GO:0002710) | 3.89466119 |
26 | response to peptidoglycan (GO:0032494) | 3.81147280 |
27 | regulation of gamma-delta T cell activation (GO:0046643) | 3.80411436 |
28 | NIK/NF-kappaB signaling (GO:0038061) | 3.79598349 |
29 | leukocyte aggregation (GO:0070486) | 3.79531748 |
30 | germinal center formation (GO:0002467) | 3.79409073 |
31 | positive T cell selection (GO:0043368) | 3.79098469 |
32 | macrophage activation involved in immune response (GO:0002281) | 3.78069537 |
33 | detection of bacterium (GO:0016045) | 3.74052781 |
34 | neutrophil activation (GO:0042119) | 3.73942997 |
35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.72626829 |
36 | negative regulation of cell killing (GO:0031342) | 3.72323050 |
37 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.72323050 |
38 | detection of external biotic stimulus (GO:0098581) | 3.67256394 |
39 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.66654379 |
40 | negative regulation of phagocytosis (GO:0050765) | 3.63190726 |
41 | response to interleukin-15 (GO:0070672) | 3.62848624 |
42 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.60699087 |
43 | * mast cell activation (GO:0045576) | 3.59656691 |
44 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.55614627 |
45 | T cell selection (GO:0045058) | 3.52347621 |
46 | granulocyte activation (GO:0036230) | 3.48097900 |
47 | histone H3-K36 demethylation (GO:0070544) | 3.46822014 |
48 | * myeloid cell activation involved in immune response (GO:0002275) | 3.43531587 |
49 | * respiratory burst (GO:0045730) | 3.43157187 |
50 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.39321691 |
51 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.39321691 |
52 | megakaryocyte development (GO:0035855) | 3.38985872 |
53 | detection of biotic stimulus (GO:0009595) | 3.37938146 |
54 | activated T cell proliferation (GO:0050798) | 3.37779425 |
55 | positive regulation of interferon-alpha production (GO:0032727) | 3.37551110 |
56 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.35378926 |
57 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.34659627 |
58 | response to muramyl dipeptide (GO:0032495) | 3.31650051 |
59 | B cell mediated immunity (GO:0019724) | 3.29697817 |
60 | cellular response to zinc ion (GO:0071294) | 3.29048047 |
61 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.27222393 |
62 | regulation of interferon-alpha production (GO:0032647) | 3.26516922 |
63 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.25528480 |
64 | cellular response to interleukin-15 (GO:0071350) | 3.24816864 |
65 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.21555463 |
66 | response to host immune response (GO:0052572) | 3.18345580 |
67 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.18345580 |
68 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.17242384 |
69 | thymic T cell selection (GO:0045061) | 3.16206750 |
70 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.15584576 |
71 | * cellular extravasation (GO:0045123) | 3.11092712 |
72 | myeloid dendritic cell activation (GO:0001773) | 3.09754773 |
73 | myeloid leukocyte mediated immunity (GO:0002444) | 3.05247827 |
74 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.04504891 |
75 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.03119913 |
76 | defense response to protozoan (GO:0042832) | 3.02509633 |
77 | positive regulation of mast cell degranulation (GO:0043306) | 3.02250333 |
78 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.02250333 |
79 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.01720613 |
80 | response to host (GO:0075136) | 3.00723240 |
81 | response to host defenses (GO:0052200) | 3.00723240 |
82 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.00723240 |
83 | response to protozoan (GO:0001562) | 3.00677384 |
84 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.00389572 |
85 | neutrophil mediated immunity (GO:0002446) | 2.99082935 |
86 | negative regulation of granulocyte differentiation (GO:0030853) | 2.97085762 |
87 | regulation of granulocyte differentiation (GO:0030852) | 2.96726788 |
88 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.96560531 |
89 | mature B cell differentiation (GO:0002335) | 2.96395200 |
90 | regulation of mast cell degranulation (GO:0043304) | 2.96284211 |
91 | microglial cell activation (GO:0001774) | 2.94120648 |
92 | negative regulation of adaptive immune response (GO:0002820) | 2.92702617 |
93 | positive regulation of antigen processing and presentation (GO:0002579) | 2.91104644 |
94 | * mast cell degranulation (GO:0043303) | 2.90907671 |
95 | * mast cell activation involved in immune response (GO:0002279) | 2.90907671 |
96 | regulation of leukocyte degranulation (GO:0043300) | 2.89861877 |
97 | T cell homeostasis (GO:0043029) | 2.87907049 |
98 | negative regulation of interleukin-12 production (GO:0032695) | 2.87608172 |
99 | * myeloid leukocyte activation (GO:0002274) | 2.87580762 |
100 | cellular response to type I interferon (GO:0071357) | 2.86580671 |
101 | type I interferon signaling pathway (GO:0060337) | 2.86580671 |
102 | interferon-gamma production (GO:0032609) | 2.84603272 |
103 | B cell homeostasis (GO:0001782) | 2.83352441 |
104 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.83130776 |
105 | negative regulation of B cell proliferation (GO:0030889) | 2.82860037 |
106 | * T cell migration (GO:0072678) | 2.82369963 |
107 | tolerance induction (GO:0002507) | 2.81867934 |
108 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.81669313 |
109 | regulation of tolerance induction (GO:0002643) | 2.81520112 |
110 | positive regulation of B cell activation (GO:0050871) | 2.81514086 |
111 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.80367020 |
112 | leukocyte cell-cell adhesion (GO:0007159) | 2.79727564 |
113 | lymphocyte homeostasis (GO:0002260) | 2.77616768 |
114 | myeloid dendritic cell differentiation (GO:0043011) | 2.77572421 |
115 | regulation of mast cell activation (GO:0033003) | 2.76997702 |
116 | regulation of erythrocyte differentiation (GO:0045646) | 2.76025762 |
117 | negative thymic T cell selection (GO:0045060) | 2.75369925 |
118 | lymphoid progenitor cell differentiation (GO:0002320) | 2.75131571 |
119 | regulation of RIG-I signaling pathway (GO:0039535) | 2.75075656 |
120 | negative T cell selection (GO:0043383) | 2.74145724 |
121 | * leukocyte degranulation (GO:0043299) | 2.73889610 |
122 | dendritic cell differentiation (GO:0097028) | 2.73545751 |
123 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.70681532 |
124 | leukocyte homeostasis (GO:0001776) | 2.69926801 |
125 | positive regulation of mast cell activation (GO:0033005) | 2.68878432 |
126 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.68827081 |
127 | definitive hemopoiesis (GO:0060216) | 2.68551416 |
128 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.68006828 |
129 | macrophage activation (GO:0042116) | 2.63890391 |
130 | pinocytosis (GO:0006907) | 2.63794565 |
131 | mature B cell differentiation involved in immune response (GO:0002313) | 2.63362633 |
132 | response to fungus (GO:0009620) | 2.63349804 |
133 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.63048057 |
134 | response to type I interferon (GO:0034340) | 2.60216514 |
135 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.59309288 |
136 | positive regulation of macrophage differentiation (GO:0045651) | 2.57184250 |
137 | germ cell migration (GO:0008354) | 2.56996189 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.17584710 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.78436688 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.08581390 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.04404658 |
5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.01350088 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.68005165 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.67200367 |
8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.65524677 |
9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.58906508 |
10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.45177290 |
11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.34489098 |
12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.27530707 |
13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.19634092 |
14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.16337438 |
15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.89698669 |
16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.80195078 |
17 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.60655623 |
18 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.57967080 |
19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.56359027 |
20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.55257979 |
21 | MYC_22102868_ChIP-Seq_BL_Human | 2.53899908 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 2.39454658 |
23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.37149137 |
24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.36875069 |
25 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.34698824 |
26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.32874372 |
27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.29452999 |
28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.27400899 |
29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.27214831 |
30 | MAF_26560356_Chip-Seq_TH1_Human | 2.25761723 |
31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.25438691 |
32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.22760610 |
33 | GATA1_22025678_ChIP-Seq_K562_Human | 2.21311810 |
34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.20626782 |
35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10114990 |
36 | MYB_26560356_Chip-Seq_TH1_Human | 2.07846094 |
37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04637852 |
38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.90914622 |
39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.88884527 |
40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.83000983 |
41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79831162 |
42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.79187038 |
43 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77843576 |
44 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.77330279 |
45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75851557 |
46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63964911 |
47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.63770314 |
48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.61210460 |
49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.60940322 |
50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56701238 |
51 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.51874844 |
52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48256771 |
53 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.46115660 |
54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44237011 |
55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43521383 |
56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42022732 |
57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.40129375 |
58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38964159 |
59 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.34576843 |
60 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28792117 |
61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28351064 |
62 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.26998934 |
63 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.23386832 |
64 | MAF_26560356_Chip-Seq_TH2_Human | 1.22184466 |
65 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.22023916 |
66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21928316 |
67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20851969 |
68 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.19665041 |
69 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.18823634 |
70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17306038 |
71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15378965 |
72 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.14037704 |
73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13053087 |
74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12611165 |
75 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.11217033 |
76 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10962660 |
77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09951715 |
78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09482507 |
79 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.05733920 |
80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03741942 |
81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02515396 |
82 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02274047 |
83 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02265445 |
84 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.00721704 |
85 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.98474481 |
86 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96677284 |
87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96201277 |
88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95759168 |
89 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.94513407 |
90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93823636 |
91 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93796253 |
92 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93093750 |
93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92078861 |
94 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92047800 |
95 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91484342 |
96 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90302319 |
97 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.88886125 |
98 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.88190168 |
99 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88070080 |
100 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.85028157 |
101 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83450866 |
102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83406873 |
103 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82054837 |
104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81807053 |
105 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.81140461 |
106 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81131844 |
107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.79859411 |
108 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78640130 |
109 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78377325 |
110 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.77503072 |
111 | GATA3_26560356_Chip-Seq_TH1_Human | 0.76594429 |
112 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75915694 |
113 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.74775298 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.27286511 |
2 | MP0005671_abnormal_response_to | 3.33509274 |
3 | MP0002396_abnormal_hematopoietic_system | 3.26221454 |
4 | * MP0003436_decreased_susceptibility_to | 2.99096084 |
5 | MP0009785_altered_susceptibility_to | 2.98325798 |
6 | * MP0001800_abnormal_humoral_immune | 2.96905486 |
7 | * MP0005000_abnormal_immune_tolerance | 2.83846530 |
8 | * MP0002452_abnormal_antigen_presenting | 2.77591124 |
9 | * MP0002419_abnormal_innate_immunity | 2.76529154 |
10 | MP0000685_abnormal_immune_system | 2.75063658 |
11 | MP0003303_peritoneal_inflammation | 2.73845387 |
12 | MP0001790_abnormal_immune_system | 2.67975688 |
13 | MP0005387_immune_system_phenotype | 2.67975688 |
14 | MP0002148_abnormal_hypersensitivity_rea | 2.67109205 |
15 | * MP0005025_abnormal_response_to | 2.62838199 |
16 | * MP0002723_abnormal_immune_serum | 2.58843091 |
17 | * MP0002420_abnormal_adaptive_immunity | 2.57935009 |
18 | * MP0001819_abnormal_immune_cell | 2.55426718 |
19 | * MP0005464_abnormal_platelet_physiology | 2.53869576 |
20 | * MP0002398_abnormal_bone_marrow | 2.37935357 |
21 | MP0004808_abnormal_hematopoietic_stem | 2.33947881 |
22 | MP0003300_gastrointestinal_ulcer | 2.27773877 |
23 | MP0005058_abnormal_lysosome_morphology | 2.19389442 |
24 | MP0003763_abnormal_thymus_physiology | 2.16277076 |
25 | MP0009278_abnormal_bone_marrow | 2.15558150 |
26 | * MP0000716_abnormal_immune_system | 2.11818432 |
27 | MP0006082_CNS_inflammation | 2.10872910 |
28 | MP0000689_abnormal_spleen_morphology | 2.06940829 |
29 | MP0003724_increased_susceptibility_to | 2.06560765 |
30 | MP0010155_abnormal_intestine_physiology | 1.99275106 |
31 | MP0005174_abnormal_tail_pigmentation | 1.96985351 |
32 | * MP0002722_abnormal_immune_system | 1.96043537 |
33 | MP0002405_respiratory_system_inflammati | 1.95590947 |
34 | MP0003183_abnormal_peptide_metabolism | 1.95096961 |
35 | MP0001545_abnormal_hematopoietic_system | 1.93369510 |
36 | MP0005397_hematopoietic_system_phenotyp | 1.93369510 |
37 | MP0002166_altered_tumor_susceptibility | 1.93035673 |
38 | MP0000465_gastrointestinal_hemorrhage | 1.92325767 |
39 | MP0005451_abnormal_body_composition | 1.92214448 |
40 | MP0001853_heart_inflammation | 1.87639195 |
41 | MP0009333_abnormal_splenocyte_physiolog | 1.86842399 |
42 | * MP0002429_abnormal_blood_cell | 1.84369387 |
43 | MP0005075_abnormal_melanosome_morpholog | 1.79661378 |
44 | * MP0001845_abnormal_inflammatory_respons | 1.74201489 |
45 | MP0003172_abnormal_lysosome_physiology | 1.72312222 |
46 | MP0002006_tumorigenesis | 1.69727803 |
47 | MP0008260_abnormal_autophagy | 1.68901093 |
48 | MP0003191_abnormal_cellular_cholesterol | 1.65451264 |
49 | * MP0000703_abnormal_thymus_morphology | 1.56061281 |
50 | MP0004947_skin_inflammation | 1.53078910 |
51 | * MP0001533_abnormal_skeleton_physiology | 1.52732416 |
52 | MP0004381_abnormal_hair_follicle | 1.45862852 |
53 | MP0000490_abnormal_crypts_of | 1.41623383 |
54 | MP0002132_abnormal_respiratory_system | 1.40236097 |
55 | MP0008469_abnormal_protein_level | 1.37808758 |
56 | MP0004510_myositis | 1.37734791 |
57 | MP0000858_altered_metastatic_potential | 1.36686334 |
58 | MP0002009_preneoplasia | 1.32536548 |
59 | MP0003866_abnormal_defecation | 1.31030735 |
60 | MP0001873_stomach_inflammation | 1.30207541 |
61 | MP0005310_abnormal_salivary_gland | 1.29510713 |
62 | MP0000343_altered_response_to | 1.28938724 |
63 | MP0004883_abnormal_blood_vessel | 1.28611833 |
64 | MP0000569_abnormal_digit_pigmentation | 1.20277213 |
65 | MP0008007_abnormal_cellular_replicative | 1.17739402 |
66 | MP0003448_altered_tumor_morphology | 1.12313294 |
67 | MP0003075_altered_response_to | 1.08921212 |
68 | MP0008057_abnormal_DNA_replication | 1.08509605 |
69 | MP0010307_abnormal_tumor_latency | 1.04521113 |
70 | MP0010352_gastrointestinal_tract_polyps | 1.04127173 |
71 | MP0010094_abnormal_chromosome_stability | 1.04075812 |
72 | MP0009764_decreased_sensitivity_to | 1.01187036 |
73 | MP0001851_eye_inflammation | 1.00790091 |
74 | MP0002933_joint_inflammation | 0.97632981 |
75 | MP0009840_abnormal_foam_cell | 0.96455572 |
76 | MP0002019_abnormal_tumor_incidence | 0.95968940 |
77 | MP0008004_abnormal_stomach_pH | 0.95651099 |
78 | MP0003656_abnormal_erythrocyte_physiolo | 0.94955131 |
79 | MP0003943_abnormal_hepatobiliary_system | 0.92509962 |
80 | * MP0009763_increased_sensitivity_to | 0.89417992 |
81 | MP0003828_pulmonary_edema | 0.88300822 |
82 | MP0000371_diluted_coat_color | 0.86565290 |
83 | MP0002877_abnormal_melanocyte_morpholog | 0.86376864 |
84 | MP0002998_abnormal_bone_remodeling | 0.85209592 |
85 | MP0002095_abnormal_skin_pigmentation | 0.84962780 |
86 | MP0005164_abnormal_response_to | 0.83745346 |
87 | MP0000015_abnormal_ear_pigmentation | 0.83692445 |
88 | MP0006054_spinal_hemorrhage | 0.81242423 |
89 | MP0002138_abnormal_hepatobiliary_system | 0.78434357 |
90 | MP0000604_amyloidosis | 0.77681622 |
91 | MP0003690_abnormal_glial_cell | 0.77223450 |
92 | MP0008058_abnormal_DNA_repair | 0.77129252 |
93 | MP0008873_increased_physiological_sensi | 0.74116731 |
94 | MP0004130_abnormal_muscle_cell | 0.72440950 |
95 | MP0001986_abnormal_taste_sensitivity | 0.71517629 |
96 | MP0000249_abnormal_blood_vessel | 0.70667817 |
97 | MP0003077_abnormal_cell_cycle | 0.70647290 |
98 | MP0005166_decreased_susceptibility_to | 0.70279685 |
99 | MP0003045_fibrosis | 0.68957482 |
100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65286735 |
101 | MP0001663_abnormal_digestive_system | 0.64891352 |
102 | MP0009765_abnormal_xenobiotic_induced | 0.64616101 |
103 | MP0005023_abnormal_wound_healing | 0.64579953 |
104 | MP0003111_abnormal_nucleus_morphology | 0.62947906 |
105 | MP0003795_abnormal_bone_structure | 0.62570364 |
106 | MP0003091_abnormal_cell_migration | 0.61260727 |
107 | MP0005076_abnormal_cell_differentiation | 0.59815668 |
108 | MP0009115_abnormal_fat_cell | 0.58215385 |
109 | MP0000313_abnormal_cell_death | 0.58211194 |
110 | MP0003566_abnormal_cell_adhesion | 0.57939426 |
111 | MP0000477_abnormal_intestine_morphology | 0.56983549 |
112 | MP0004147_increased_porphyrin_level | 0.56672419 |
113 | MP0002075_abnormal_coat/hair_pigmentati | 0.55887234 |
114 | * MP0005390_skeleton_phenotype | 0.55204225 |
115 | MP0002136_abnormal_kidney_physiology | 0.54660734 |
116 | MP0000598_abnormal_liver_morphology | 0.53889613 |
117 | MP0004484_altered_response_of | 0.52120827 |
118 | MP0000609_abnormal_liver_physiology | 0.50135337 |
119 | MP0002277_abnormal_respiratory_mucosa | 0.49824025 |
120 | MP0008874_decreased_physiological_sensi | 0.48369358 |
121 | MP0002332_abnormal_exercise_endurance | 0.45679674 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.30409502 |
2 | Recurrent bacterial skin infections (HP:0005406) | 4.87185891 |
3 | Prostate neoplasm (HP:0100787) | 4.62228484 |
4 | Eczematoid dermatitis (HP:0000976) | 4.53327766 |
5 | Agnosia (HP:0010524) | 4.10280471 |
6 | Vacuolated lymphocytes (HP:0001922) | 4.06492499 |
7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.06451522 |
8 | Myositis (HP:0100614) | 4.05837167 |
9 | Increased cerebral lipofuscin (HP:0011813) | 3.96862681 |
10 | Cellulitis (HP:0100658) | 3.89686097 |
11 | Recurrent viral infections (HP:0004429) | 3.83025006 |
12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.76616502 |
13 | Agammaglobulinemia (HP:0004432) | 3.76120057 |
14 | Abnormality of the prostate (HP:0008775) | 3.75425702 |
15 | Recurrent fungal infections (HP:0002841) | 3.66544770 |
16 | Gastrointestinal stroma tumor (HP:0100723) | 3.56388782 |
17 | Gastrointestinal infarctions (HP:0005244) | 3.50945357 |
18 | Meningitis (HP:0001287) | 3.48653061 |
19 | Thrombocytosis (HP:0001894) | 3.45806585 |
20 | IgM deficiency (HP:0002850) | 3.32142701 |
21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.32018963 |
22 | Recurrent skin infections (HP:0001581) | 3.31428437 |
23 | Vasculitis (HP:0002633) | 3.25087880 |
24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.19289211 |
25 | Obstructive lung disease (HP:0006536) | 3.19289211 |
26 | Cerebellar dysplasia (HP:0007033) | 3.19221609 |
27 | Mediastinal lymphadenopathy (HP:0100721) | 3.19212719 |
28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.13290543 |
29 | Prolonged bleeding time (HP:0003010) | 3.08387915 |
30 | Abnormality of macrophages (HP:0004311) | 3.08309078 |
31 | Orchitis (HP:0100796) | 3.06428090 |
32 | Panhypogammaglobulinemia (HP:0003139) | 3.02898234 |
33 | Inflammation of the large intestine (HP:0002037) | 2.97430674 |
34 | Retrobulbar optic neuritis (HP:0100654) | 2.94882055 |
35 | Optic neuritis (HP:0100653) | 2.94882055 |
36 | Autoimmune hemolytic anemia (HP:0001890) | 2.94584362 |
37 | Anterior segment dysgenesis (HP:0007700) | 2.93694338 |
38 | Chronic otitis media (HP:0000389) | 2.92798720 |
39 | Colitis (HP:0002583) | 2.91261231 |
40 | Axonal loss (HP:0003447) | 2.89093683 |
41 | Gastrointestinal inflammation (HP:0004386) | 2.88295767 |
42 | Hemoptysis (HP:0002105) | 2.87910182 |
43 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.87656602 |
44 | Spontaneous hematomas (HP:0007420) | 2.86343868 |
45 | Recurrent cutaneous fungal infections (HP:0011370) | 2.86130692 |
46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.86130692 |
47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.85225348 |
48 | Petechiae (HP:0000967) | 2.82757838 |
49 | Osteomyelitis (HP:0002754) | 2.79441578 |
50 | Amaurosis fugax (HP:0100576) | 2.78875622 |
51 | Epistaxis (HP:0000421) | 2.75387524 |
52 | Increased IgE level (HP:0003212) | 2.65651214 |
53 | Abnormality of T cells (HP:0002843) | 2.63933571 |
54 | Recurrent bronchitis (HP:0002837) | 2.62988310 |
55 | Lymphopenia (HP:0001888) | 2.62918346 |
56 | Abnormality of T cell physiology (HP:0011840) | 2.62900168 |
57 | Periodontitis (HP:0000704) | 2.61523003 |
58 | Autoimmune thrombocytopenia (HP:0001973) | 2.59377063 |
59 | Arterial thrombosis (HP:0004420) | 2.57766614 |
60 | Systemic lupus erythematosus (HP:0002725) | 2.55981922 |
61 | B lymphocytopenia (HP:0010976) | 2.55175757 |
62 | Abnormality of B cell number (HP:0010975) | 2.55175757 |
63 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.54962310 |
64 | T lymphocytopenia (HP:0005403) | 2.54552526 |
65 | Thyroiditis (HP:0100646) | 2.54324042 |
66 | Abnormality of T cell number (HP:0011839) | 2.53207472 |
67 | Severe combined immunodeficiency (HP:0004430) | 2.51247937 |
68 | Gingival bleeding (HP:0000225) | 2.50811701 |
69 | Pulmonary embolism (HP:0002204) | 2.49260183 |
70 | Leukocytosis (HP:0001974) | 2.43927116 |
71 | Abnormality of eosinophils (HP:0001879) | 2.42345153 |
72 | Eosinophilia (HP:0001880) | 2.42145505 |
73 | Acute myeloid leukemia (HP:0004808) | 2.41962491 |
74 | Interstitial pulmonary disease (HP:0006530) | 2.40336096 |
75 | Pulmonary infiltrates (HP:0002113) | 2.36757145 |
76 | Viral hepatitis (HP:0006562) | 2.35353155 |
77 | Verrucae (HP:0200043) | 2.34358656 |
78 | Papilloma (HP:0012740) | 2.34358656 |
79 | Keratoconjunctivitis sicca (HP:0001097) | 2.33140288 |
80 | Impaired platelet aggregation (HP:0003540) | 2.32848035 |
81 | Abnormal platelet function (HP:0011869) | 2.32848035 |
82 | Hypoplasia of the thymus (HP:0000778) | 2.32079454 |
83 | Gingivitis (HP:0000230) | 2.31685699 |
84 | Stomatitis (HP:0010280) | 2.31429443 |
85 | Urticaria (HP:0001025) | 2.30299873 |
86 | Bundle branch block (HP:0011710) | 2.27798146 |
87 | Lymphoma (HP:0002665) | 2.26184065 |
88 | Encephalitis (HP:0002383) | 2.25663056 |
89 | Increased IgM level (HP:0003496) | 2.25630116 |
90 | Purpura (HP:0000979) | 2.25143765 |
91 | Gangrene (HP:0100758) | 2.24908156 |
92 | Granulocytopenia (HP:0001913) | 2.23412744 |
93 | IgG deficiency (HP:0004315) | 2.21373729 |
94 | Episodic fever (HP:0001954) | 2.21258091 |
95 | Chest pain (HP:0100749) | 2.21082315 |
96 | Anorexia (HP:0002039) | 2.19071963 |
97 | Pustule (HP:0200039) | 2.16438334 |
98 | Combined immunodeficiency (HP:0005387) | 2.16278510 |
99 | Spondylolisthesis (HP:0003302) | 2.14767789 |
100 | Abnormality of the fingertips (HP:0001211) | 2.14726812 |
101 | Dysostosis multiplex (HP:0000943) | 2.14703507 |
102 | Abnormality of the pleura (HP:0002103) | 2.14038140 |
103 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.13889200 |
104 | Type II lissencephaly (HP:0007260) | 2.13724896 |
105 | Glomerulonephritis (HP:0000099) | 2.12977385 |
106 | Chronic diarrhea (HP:0002028) | 2.12180235 |
107 | Acute hepatic failure (HP:0006554) | 2.11831872 |
108 | Sepsis (HP:0100806) | 2.11294485 |
109 | Keratoconjunctivitis (HP:0001096) | 2.09250206 |
110 | Recurrent pneumonia (HP:0006532) | 2.05997158 |
111 | Nasal polyposis (HP:0100582) | 2.00868059 |
112 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.00157649 |
113 | Abnormality of glycolipid metabolism (HP:0010969) | 2.00157649 |
114 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.00157649 |
115 | Fatigue (HP:0012378) | 1.99738266 |
116 | Slow saccadic eye movements (HP:0000514) | 1.99587793 |
117 | Hypochromic anemia (HP:0001931) | 1.97418510 |
118 | Abnormal platelet volume (HP:0011876) | 1.97280215 |
119 | Emphysema (HP:0002097) | 1.96819447 |
120 | Acute lymphatic leukemia (HP:0006721) | 1.95993156 |
121 | Hematochezia (HP:0002573) | 1.95770710 |
122 | Hypochromic microcytic anemia (HP:0004840) | 1.95629190 |
123 | Recurrent lower respiratory tract infections (HP:0002783) | 1.95329827 |
124 | Skin rash (HP:0000988) | 1.94806056 |
125 | Vertigo (HP:0002321) | 1.94505053 |
126 | Increased mean platelet volume (HP:0011877) | 1.94470258 |
127 | Abnormality of the peritoneum (HP:0002585) | 1.93611787 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.96672184 |
2 | KIT | 3.95887170 |
3 | MAP3K14 | 3.29940175 |
4 | MAP3K10 | 3.26811564 |
5 | RIPK4 | 2.98649728 |
6 | FLT3 | 2.79539751 |
7 | IRAK4 | 2.64350348 |
8 | BLK | 2.62857752 |
9 | CSF1R | 2.60000735 |
10 | PRPF4B | 2.45276181 |
11 | TXK | 2.36530206 |
12 | TGFBR2 | 2.29840281 |
13 | BTK | 2.29138534 |
14 | TYK2 | 2.28189272 |
15 | TEC | 2.04788227 |
16 | TBK1 | 2.02612855 |
17 | CLK1 | 2.02165736 |
18 | MATK | 1.96534067 |
19 | ZAP70 | 1.83390827 |
20 | IKBKE | 1.82386666 |
21 | SYK | 1.81852003 |
22 | STK10 | 1.81236476 |
23 | JAK3 | 1.80197930 |
24 | ERN1 | 1.75173496 |
25 | EEF2K | 1.69898714 |
26 | IKBKB | 1.63072401 |
27 | MAP2K3 | 1.51592913 |
28 | IRAK3 | 1.50636196 |
29 | ITK | 1.47866150 |
30 | GRK6 | 1.46988560 |
31 | LCK | 1.44081441 |
32 | HCK | 1.39396559 |
33 | FES | 1.30540054 |
34 | LYN | 1.30430859 |
35 | FGR | 1.26898045 |
36 | JAK1 | 1.25814229 |
37 | RPS6KA4 | 1.24775910 |
38 | TAOK3 | 1.23102047 |
39 | IRAK1 | 1.18861116 |
40 | CSK | 1.18209529 |
41 | EPHB1 | 1.16768835 |
42 | MAP3K13 | 1.16604739 |
43 | PKN2 | 1.16020683 |
44 | PIM1 | 1.12850788 |
45 | MAP3K1 | 1.07680255 |
46 | CHUK | 1.07278468 |
47 | LRRK2 | 1.02075757 |
48 | KSR2 | 1.01253799 |
49 | CAMKK2 | 0.98035280 |
50 | STK4 | 0.95392953 |
51 | MAP3K11 | 0.91915998 |
52 | MAP3K3 | 0.91728206 |
53 | MAP3K2 | 0.89231329 |
54 | TRIB3 | 0.84344458 |
55 | NEK9 | 0.81910866 |
56 | MARK2 | 0.77388943 |
57 | IRAK2 | 0.76215892 |
58 | JAK2 | 0.76047934 |
59 | SIK2 | 0.75988817 |
60 | MAPK12 | 0.75590106 |
61 | NLK | 0.74912944 |
62 | PIK3CA | 0.72731946 |
63 | PIM2 | 0.72284696 |
64 | FGFR3 | 0.67312129 |
65 | TRPM7 | 0.66713270 |
66 | TAOK1 | 0.66279552 |
67 | BRD4 | 0.66135922 |
68 | MAPK4 | 0.66009898 |
69 | PAK4 | 0.65443824 |
70 | RAF1 | 0.65098688 |
71 | SGK2 | 0.64705646 |
72 | TGFBR1 | 0.64328059 |
73 | RPS6KA6 | 0.63792154 |
74 | SIK3 | 0.61544461 |
75 | SGK3 | 0.61255119 |
76 | PTK2B | 0.59270235 |
77 | PDPK1 | 0.58546171 |
78 | MAP3K5 | 0.58154556 |
79 | VRK1 | 0.57936218 |
80 | CDK12 | 0.56363798 |
81 | YES1 | 0.56284766 |
82 | WNK1 | 0.53862161 |
83 | RPS6KC1 | 0.52853977 |
84 | RPS6KL1 | 0.52853977 |
85 | RET | 0.52004296 |
86 | ADRBK2 | 0.51450339 |
87 | CDK4 | 0.51277968 |
88 | TESK2 | 0.50892839 |
89 | CDK6 | 0.49989890 |
90 | CAMK1D | 0.49511426 |
91 | TAOK2 | 0.49072174 |
92 | NEK2 | 0.48768419 |
93 | MAPKAPK2 | 0.48744117 |
94 | CDC7 | 0.48184662 |
95 | GRK7 | 0.47638536 |
96 | MAP3K12 | 0.46964821 |
97 | TNK2 | 0.46080731 |
98 | MAP2K6 | 0.45715813 |
99 | MAP3K8 | 0.42769246 |
100 | STK24 | 0.42540977 |
101 | PRKCQ | 0.41986956 |
102 | MARK3 | 0.41154260 |
103 | ATR | 0.41041768 |
104 | MAPK7 | 0.39325610 |
105 | PTK6 | 0.39093413 |
106 | HIPK2 | 0.38878065 |
107 | CAMKK1 | 0.38756993 |
108 | PDK1 | 0.38152948 |
109 | RPS6KB2 | 0.37015988 |
110 | CCNB1 | 0.36588740 |
111 | ABL1 | 0.35994975 |
112 | NME2 | 0.35561773 |
113 | KSR1 | 0.35506962 |
114 | MAPKAPK3 | 0.34782078 |
115 | MAP3K7 | 0.34432287 |
116 | FGFR4 | 0.32349758 |
117 | EPHA3 | 0.31499073 |
118 | PRKG2 | 0.30575350 |
119 | FYN | 0.30133521 |
120 | PRKCD | 0.29965182 |
121 | MAPK11 | 0.29453610 |
122 | STK11 | 0.29451000 |
123 | ALK | 0.29379986 |
124 | RPS6KA2 | 0.28831681 |
125 | RPS6KA5 | 0.28754551 |
126 | MAPK3 | 0.27801498 |
127 | IGF1R | 0.26392478 |
128 | BMPR2 | 0.25530340 |
129 | CAMK4 | 0.25431036 |
130 | MAP3K6 | 0.24352457 |
131 | EGFR | 0.23389031 |
132 | TTN | 0.23377672 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.13646908 |
2 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.91320014 |
3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.75255113 |
4 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.62906198 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.34624297 |
6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.22503872 |
7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19215084 |
8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.16736202 |
9 | * Measles_Homo sapiens_hsa05162 | 2.14172891 |
10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.12257516 |
11 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.10882668 |
12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.00745575 |
13 | Legionellosis_Homo sapiens_hsa05134 | 1.99969254 |
14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.90416329 |
15 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.87642366 |
16 | Pertussis_Homo sapiens_hsa05133 | 1.84315382 |
17 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.79551270 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.69115606 |
19 | DNA replication_Homo sapiens_hsa03030 | 1.66150158 |
20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.65838555 |
21 | Mismatch repair_Homo sapiens_hsa03430 | 1.63807001 |
22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63676228 |
23 | Tuberculosis_Homo sapiens_hsa05152 | 1.62074750 |
24 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.61135288 |
25 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.59242295 |
26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.57900056 |
27 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.54883769 |
28 | Allograft rejection_Homo sapiens_hsa05330 | 1.54313629 |
29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52240420 |
30 | * Influenza A_Homo sapiens_hsa05164 | 1.51587012 |
31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.50201136 |
32 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.48516441 |
33 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.46603071 |
34 | Asthma_Homo sapiens_hsa05310 | 1.42855564 |
35 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40702222 |
36 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.40161263 |
37 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36678522 |
38 | Malaria_Homo sapiens_hsa05144 | 1.35906427 |
39 | Shigellosis_Homo sapiens_hsa05131 | 1.33476639 |
40 | Lysosome_Homo sapiens_hsa04142 | 1.32936881 |
41 | * Hepatitis B_Homo sapiens_hsa05161 | 1.29765507 |
42 | * Platelet activation_Homo sapiens_hsa04611 | 1.26832476 |
43 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.25980861 |
44 | * Apoptosis_Homo sapiens_hsa04210 | 1.23520248 |
45 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21797436 |
46 | Salmonella infection_Homo sapiens_hsa05132 | 1.20142692 |
47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.19946485 |
48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17245369 |
49 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.12758861 |
50 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09114084 |
51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04245686 |
52 | Base excision repair_Homo sapiens_hsa03410 | 0.96084002 |
53 | * Pancreatic cancer_Homo sapiens_hsa05212 | 0.94682771 |
54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.93218732 |
55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.92536351 |
56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90827112 |
57 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87175670 |
58 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85956612 |
59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84925585 |
60 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82847122 |
61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.81911692 |
62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80922131 |
63 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78761368 |
64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78719436 |
65 | Phagosome_Homo sapiens_hsa04145 | 0.78584374 |
66 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78456816 |
67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71616688 |
68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70928026 |
69 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70906523 |
70 | * Hepatitis C_Homo sapiens_hsa05160 | 0.69431380 |
71 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.68438704 |
72 | Homologous recombination_Homo sapiens_hsa03440 | 0.67665568 |
73 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67328642 |
74 | Ribosome_Homo sapiens_hsa03010 | 0.66982763 |
75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66604356 |
76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66020072 |
77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65091120 |
78 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.64553539 |
79 | * Small cell lung cancer_Homo sapiens_hsa05222 | 0.59136031 |
80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58550836 |
81 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.53997759 |
82 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53342707 |
83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52887924 |
84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52723436 |
85 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50728632 |
86 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49654936 |
87 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48680906 |
88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47988911 |
89 | * Colorectal cancer_Homo sapiens_hsa05210 | 0.46535996 |
90 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45758461 |
91 | Cell cycle_Homo sapiens_hsa04110 | 0.45250927 |
92 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44651941 |
93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43297201 |
94 | * Endometrial cancer_Homo sapiens_hsa05213 | 0.41495213 |
95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39850628 |
96 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39440064 |
97 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39428042 |
98 | Endocytosis_Homo sapiens_hsa04144 | 0.37618714 |
99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37303430 |
100 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37294711 |
101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37044926 |
102 | * Prostate cancer_Homo sapiens_hsa05215 | 0.36480662 |
103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34885376 |
104 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34235798 |
105 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33141815 |
106 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32875347 |
107 | * Glioma_Homo sapiens_hsa05214 | 0.32838209 |
108 | Spliceosome_Homo sapiens_hsa03040 | 0.32399457 |
109 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32275869 |
110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.32039044 |
111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31883615 |
112 | * Amoebiasis_Homo sapiens_hsa05146 | 0.31480077 |
113 | * Insulin resistance_Homo sapiens_hsa04931 | 0.31015925 |
114 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30492375 |
115 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30039095 |
116 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29736002 |
117 | Long-term potentiation_Homo sapiens_hsa04720 | 0.29627429 |
118 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.27935245 |
119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27756288 |
120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26666898 |
121 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.25900700 |
122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25224542 |